News & Updates

Show Multimedia Only
Score model predicts prognosis in older adults with pneumonia
Score model predicts prognosis in older adults with pneumonia
10 Aug 2024
Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma
Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma
08 Aug 2024 byStephen Padilla

In patients with relapsed/refractory multiple myeloma (RRMM) who received at least one prior line of therapy (LOT), treatment with belantamab mafodotin (belamaf) plus pomalidomide and dexamethasone (BPD) results in statistically significant and clinically meaningful progressive-free survival (PFS) compared with pomalidomide plus bortezomib and dexamethasone (PVD), as shown in the DREAMM-8 study.

Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma
08 Aug 2024
New risk factor identified for sudden infant death: Maternal obesity
New risk factor identified for sudden infant death: Maternal obesity
08 Aug 2024